Aflibercept-Based and Bevacizumab-Based Second Line Regimens in Patients with Metastatic Colorectal Cancer: Propensity Score Weighted-Analysis from a Multicenter Cohort
Title:
Aflibercept-Based and Bevacizumab-Based Second Line Regimens in Patients with Metastatic Colorectal Cancer: Propensity Score Weighted-Analysis from a Multicenter Cohort
Author:
Lucchetti, Jessica Angotti, Lorenzo Parisi, Alessandro Basso, Michele Polito, Mariam Grazia Zoratto, Federica Di Giacomo, Emanuela Nitti, Daniele Minelli, Alessandro Salvatore, Lisa Calegari, Maria Alessandra Lo Prinzi, Federica Gemma, Donatello Signorelli, Carlo Veroli, Margherita Anghelone, Annunziato Galbato Muscio, Luca Di Cocco, Barbara Trombetta, Giorgio Morelli, Cristina Schietroma, Francesco Vincenzi, Bruno Cortellini, Alessio Tonini, Giuseppe